Q32 Bio Inc.QTTBNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | -680.53% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | -1172.01% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | -1142.87% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | -1142.87% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +275.74% | +278.43% | +2.14% | +1.95% | +1.36% |
| Weighted Average Shares Diluted Growth | +275.74% | +278.43% | +2.14% | +1.95% | +1.36% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -222.77% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -223.14% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -17.21% | -26.49% | -1.42% | -1.42% | -100.00% |
| Inventory Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +94.43% | +96.21% | -48.09% | -46.77% | -44.73% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -60.94% | -62.82% | -6.69% | -5.82% | -41.55% |
| R&D Expense Growth | +92.23% | +26.45% | -27.61% | -61.52% | -75.22% |
| SG&A Expenses Growth | +115.85% | +41.77% | +4.61% | -8.59% | -9.98% |